Funding

The lab is grateful to past and present funding from the National Heart, Lung and Blood Institute of the National Institutes of Health, the American Society of Hematology, the American Heart Association and internal funds from UNC Chapel Hill.

Current Funding

"Regulation of coagulation and thrombosis by C1 inhibitor"

NIH/NHLBI R01HL171042

Role: Principal Investigator

09/2024-09/2029

"Mechanisms of venous thrombosis and renal dysfunction in sickle trait"

NIH/NHLBI R01HL171501 

Role: Co-Investigator

02/2024 - 02/2028

"Role of Factor XII in thrombo-inflammatory complications of sickle cell disease"

NIH/NHLBI R01HL173322

Role: Co-Investigator

07/2024 - 07/2028

Past Funding

"Revision of R01HL171042"

UNC-CH Boost Funding

Role: Principal Investigator

02/2024 - 09/2024

"The role of endogenous C1 inhibitor as a negative regulator of coagulation in the general population"

UNC-CH Faculty Development Award

Role: Principal Investigator

01/2023 - 12/2023

"Evaluating the anticoagulant activity of C1 inhibitor in venous thrombosis"

ASH Scholar Award

Role: Principal Investigator

07/2022 - 07/2024

"Determine the mechanisms by which PAR1 enhances doxorubicin-induced cardiac injury"

AHA 19POST34370026

Role: Postdocotral Fellow

01/2019 - 01/2021